Contrast Nephropathy. Nephropathy induced by other drugs, medicaments and biological substances
Conditions
Interventions
Intervention 1: Control group: Seventy-five eligible patients hospitalized at Shariati Hospital in Tehran were randomly assigned to the control group. According to the standard protocol for prevention
Sponsors
Dr. Shariati Educational, Research and Medical Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age over 18 years No history of magnesium supplement use
Exclusion criteria
Exclusion criteria: Patients with severe renal insufficiency (estimated glomerular filtration rate based on the CKD-EPI formula >30 mL/min/1.73 m2) or history of dialysis Severe liver failure Having active cancer Anemia with a hemoglobin level of less than 10 Age over 75 years Heart failure with an ejection fraction of less than 30% Mean arterial blood pressure of less than 70 before receiving contrast Magnesium levels outside the normal range History of sensitivity to contrast medium
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Contrast-Induced Nephropathy. Timepoint: Before coronary artery catheterization and 48-72 hours after coronary artery catheterization. Method of measurement: An increase of more than 0.3 mg/dL in creatinine level or a 25-50% increase in creatinine in patients within two to three days after coronary artery catheterization (based on KDIGO guidelines). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Tavakoli
Tehran University of Medical Sciences
Outcome results
None listed